Deciphera Pharmaceuticals, Inc. financial data

Location
Waltham, MA
Fiscal year end
31 December
Latest financial report
10-Q - Q1 2024 - 10 May 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 434% % -20%
Quick Ratio 29% % 8.9%
Debt-to-equity 31% % 13%
Return On Equity -52% % -13%
Return On Assets -40% % -9.4%
Operating Margin -118% % 14%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 86,475,972 shares 10%
Common Stock, Shares, Outstanding 82,158,670 shares 4.6%
Common Stock, Value, Issued $821,000 USD 4.6%
Weighted Average Number of Shares Outstanding, Basic 87,388,106 shares 5.7%
Weighted Average Number of Shares Outstanding, Diluted 87,388,106 shares 5.7%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $174,910,000 USD 27%
Research and Development Expense $237,192,000 USD 22%
Costs and Expenses $381,458,000 USD 17%
Operating Income (Loss) $206,548,000 USD -9.2%
Nonoperating Income (Expense) $16,563,000 USD 103%
Net Income (Loss) Attributable to Parent $190,374,000 USD -4.8%
Earnings Per Share, Basic -2 USD/shares -1.8%
Earnings Per Share, Diluted -2 USD/shares -1.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $91,228,000 USD -20%
Accounts Receivable, after Allowance for Credit Loss, Current $32,684,000 USD 46%
Inventory, Net $26,032,000 USD 2%
Other Assets, Current $1,386,000 USD
Assets, Current $349,937,000 USD -27%
Property, Plant and Equipment, Net $5,155,000 USD -21%
Operating Lease, Right-of-Use Asset $30,925,000 USD -13%
Assets $420,928,000 USD -23%
Accounts Payable, Current $19,459,000 USD -1.1%
Employee-related Liabilities, Current $7,918,000 USD -27%
Liabilities, Current $83,429,000 USD -0.58%
Operating Lease, Liability, Noncurrent $21,449,000 USD -14%
Liabilities $104,878,000 USD -3.7%
Accumulated Other Comprehensive Income (Loss), Net of Tax $98,000 USD
Retained Earnings (Accumulated Deficit) $1,473,388,000 USD -15%
Stockholders' Equity Attributable to Parent $316,050,000 USD -28%
Liabilities and Equity $420,928,000 USD -23%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $54,585,000 USD -10%
Net Cash Provided by (Used in) Financing Activities $522,000 USD -100%
Net Cash Provided by (Used in) Investing Activities $62,631,000 USD
Common Stock, Shares Authorized 125,000,000 shares 0%
Common Stock, Shares, Issued 82,158,670 shares 4.6%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $91,228,000 USD -20%
Payments to Acquire Property, Plant, and Equipment $146,000 USD -59%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $190,137,000 USD -4.9%
Operating Lease, Liability, Current $3,574,000 USD 8.3%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5,000,000 shares 0%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization $450,000 USD -26%
Share-based Payment Arrangement, Expense $48,263,000 USD -3.8%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%